Bacterial low-abundant taxa are key determinants of a healthy airway metagenome in the early years of human life.

Graph kernels Human airway metagenome Microbiome development Random forest Rare species

Journal

Computational and structural biotechnology journal
ISSN: 2001-0370
Titre abrégé: Comput Struct Biotechnol J
Pays: Netherlands
ID NLM: 101585369

Informations de publication

Date de publication:
2022
Historique:
received: 11 09 2021
revised: 06 12 2021
accepted: 06 12 2021
entrez: 13 1 2022
pubmed: 14 1 2022
medline: 14 1 2022
Statut: epublish

Résumé

The default removal of low-abundance (rare) taxa from microbial community analyses may lead to an incomplete picture of the taxonomic and functional microbial potential within the human habitat. Publicly available shotgun metagenomics data of healthy children and children with cystic fibrosis (CF) were reanalysed to study the development of the rare species biosphere, which was here defined by either the 15th, 25th or 35th species abundance percentile. We found that healthy children contained an age-independent network of abundant (core) and rare species with both entities being essential in maintaining the network structure. The protein sequence usage for more than 100 bacterial metabolic pathways differed between the core and rare species biosphere. In CF children, the background structure was underdeveloped and random forest bootstrapping based on all constituents of the early airway metagenome and host-associated factors indicated that rare taxa were the most important variables in deciding whether a child was healthy or suffered from the life-limiting CF disease. Attempts failed to make the age-independent CF network as robust as the healthy structure when an increasing number of bacterial taxa from the healthy network was incorporated into the CF structure by computer-based model simulations. However, the transfer of a key combination of taxa from the healthy to the CF network structure with high species diversity and low species dominance, correlated with a more robust CF network and a topological approximation of CF and healthy graph structures. Rothia mucilaginosa, Streptococci and rare species were essential in improving the underdeveloped CF network.

Identifiants

pubmed: 35024091
doi: 10.1016/j.csbj.2021.12.008
pii: S2001-0370(21)00516-X
pmc: PMC8713036
doi:

Types de publication

Journal Article

Langues

eng

Pagination

175-186

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Sci Rep. 2015 May 14;5:10241
pubmed: 25974282
Nature. 2000 Jul 27;406(6794):378-82
pubmed: 10935628
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738):
pubmed: 29203708
NAR Genom Bioinform. 2020 Dec 17;2(4):lqaa100
pubmed: 33575644
Genome Res. 2007 Mar;17(3):377-86
pubmed: 17255551
PLoS Comput Biol. 2014 Apr 03;10(4):e1003531
pubmed: 24699258
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
NPJ Precis Oncol. 2020 Dec 10;4(1):33
pubmed: 33303906
NPJ Biofilms Microbiomes. 2016 Dec 2;2:4
pubmed: 28649398
NPJ Biofilms Microbiomes. 2020 Dec 15;6(1):61
pubmed: 33319812
ISME J. 2017 Apr;11(4):853-862
pubmed: 28072420
Front Microbiol. 2014 May 20;5:219
pubmed: 24904535
Nat Rev Microbiol. 2015 Apr;13(4):217-29
pubmed: 25730701
Gastroenterology. 2021 Jan;160(2):483-494
pubmed: 33253682
Nucleic Acids Res. 2020 Jan 8;48(D1):D445-D453
pubmed: 31586394
Cell Host Microbe. 2012 Nov 15;12(5):611-22
pubmed: 23159051
Front Microbiol. 2017 Jun 23;8:1162
pubmed: 28690602
Front Genet. 2021 Sep 07;12:706907
pubmed: 34557218
mSystems. 2020 Dec 1;5(6):
pubmed: 33262240
Front Microbiol. 2018 Mar 07;9:297
pubmed: 29563898
mSystems. 2019 Feb 19;4(1):
pubmed: 30801030
Cell. 2019 Aug 8;178(4):779-794
pubmed: 31398336
Genome Biol. 2021 Mar 10;22(1):81
pubmed: 33691770
Front Bioeng Biotechnol. 2015 Jun 24;3:90
pubmed: 26157797
Sci Rep. 2018 Jan 22;8(1):1362
pubmed: 29358745
BMC Genomics. 2019 Dec 10;20(1):960
pubmed: 31823721
Genome Res. 2016 Dec;26(12):1721-1729
pubmed: 27852649
Front Microbiol. 2017 Nov 15;8:2224
pubmed: 29187837
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
mBio. 2017 Feb 14;8(1):
pubmed: 28196961
Genome Biol. 2018 Nov 16;19(1):198
pubmed: 30445993
BMC Genomics. 2018 Apr 20;19(1):274
pubmed: 29678163
PLoS One. 2016 Oct 19;11(10):e0165015
pubmed: 27760173
Mol Ecol. 2015 Nov;24(21):5428-45
pubmed: 26407082
Nucleic Acids Res. 2017 Jan 4;45(D1):D158-D169
pubmed: 27899622
Proc Biol Sci. 2016 Apr 13;283(1828):
pubmed: 27053754
Bioinformatics. 2018 Feb 1;34(3):530-532
pubmed: 29028902
Anal Chem. 2018 Jan 2;90(1):86-109
pubmed: 29061041
Cell. 2006 Feb 24;124(4):715-27
pubmed: 16497583
ERJ Open Res. 2016 May 09;2(2):
pubmed: 27730195
Nucleic Acids Res. 2019 Jan 8;47(D1):D542-D549
pubmed: 30395242
Sci Rep. 2016 Aug 25;6:31775
pubmed: 27558272
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
Ann Am Thorac Soc. 2015 Jun;12(6):821-30
pubmed: 25803243
Mucosal Immunol. 2017 Mar;10(2):299-306
pubmed: 27966551
Front Genet. 2015 Mar 31;6:119
pubmed: 25873935
Nature. 2007 Oct 18;449(7164):804-10
pubmed: 17943116
ERJ Open Res. 2017 Jan 17;3(1):
pubmed: 28154819
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
mSystems. 2019 Jan 22;4(1):
pubmed: 30687779
PLoS Comput Biol. 2021 Jan 27;17(1):e1008678
pubmed: 33503026
Nat Med. 2018 Apr 10;24(4):392-400
pubmed: 29634682
PLoS Comput Biol. 2013;9(5):e1003063
pubmed: 23737737
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Mol Ecol Resour. 2019 Jul;19(4):982-996
pubmed: 30887686

Auteurs

Marie-Madlen Pust (MM)

Department of Paediatric Pneumology, Allergology, and Neonatology, Hannover Medical School (MHH), Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover Medical School, Germany.

Burkhard Tümmler (B)

Department of Paediatric Pneumology, Allergology, and Neonatology, Hannover Medical School (MHH), Germany.
Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research, Hannover Medical School, Germany.

Classifications MeSH